Gonadorelin is a trophic peptide hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. GnRH is synthesized and released from GnRH neurons within the hypothalamus. The peptide belongs to gonadotropin-releasing hormone family. It constitutes the initial step in the hypothalamic–pituitary–gonadal axis.
CAT No: 10-101-166
CAS No:33515-09-2(net)
Synonyms/Alias:GONADORELIN;Luliberin;Gonadorelina;Gonadorelinum;33515-09-2;Fertagyl;LH-Releasing factor;Luteostimulin;Relefact;Lutal;GnRH-I;Gonadotropin-releasing factor;Mammalian GnRH;Synthetic LRF;Dirigestran Spofa;Synthetic Gn-RH;Mammalian LH-RH;Synthetic LH-RF;Synthetic LH-RH;Porchine LH-RH;Hypocrine;Human LH-RH;Ovine LH-RH;LH-RH (swine);Synthetic gonadoliberin;Gonadoreline;Synthetic LH-FSH-RH;Gonadoliberin I;5-oxo-PHWSYGLRPGNH2;Synthetic LH-RH/FSH-RH;LH-Releasing factor (pig);Porcine LH-releasing factor;Synthetic LH-releasing factor;CHEBI:5520;Human gonadoliberin-i;p-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2;UNII-9O7312W37G;Gonadorelin decapeptide;Synthetic decapeptide FSH/LH-RH;HOE 471;EINECS 251-553-1;Gonadorelinum [INN-Latin];Gonadorelina [INN-Spanish];AY 24031;9034-40-6;LH-RH;Dirigestran;Glycinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolyl-;Gonadorelinum (INN-Latin);Gonadorelina (INN-Spanish);5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide;AY-24031;Gn-RH;Luforan;Lutrefact;Nialutin;Relisorm l;LFRH;LHFSHRH;pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2;LH-RF;Gonadorelin [INN:BAN];71447-49-9;Fertelin, OvaCyst;Fertagyl (TN);EINECS 232-895-0;Gonadorelin (INN);AY 24034;CHEMBL1007;GONADORELIN (MART.);SCHEMBL143114;[125I]-GnRH I;GTPL3786;DTXSID20873490;H01CA01;V04CM01;5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (human or pig);BDBM50422274;AKOS015895122;AKOS030213247;9O7312W37G;CCG-270650;HS-2014;[125I]GnRH I (human, mouse, rat);Luteinizing hormone-areleasing factor (swine);D08027;pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-GlyNH2;GONADORELIN (GONADORELIN DECAPEPTIDE (GNRH));pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH(2);BRD-K96874295-015-01-0;GONADOTROPIN-RELEASING HORMONE (GNRH) ANALOGUE;Q20817116;5-OXOPRO-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-GLY-NH2;LUTEINISING HORMONE-RELEASING FACTOR (LNRH) ANALOGUE;251-553-1;5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl- glycyl-L-leucyl-L-arginyl-L-prolyl-glycinamide;L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide;
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More